ReviewChemical science2026
The advent of molecular nanocarbon biology.
Review in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Molecular nanocarbons, including polycyclic aromatic hydrocarbons, cycloparaphenylenes, and carbon nanobelts, have emerged as structurally well-defined carbon-rich molecules with unique photophysical, electronic, and topological properties. Recent advances in synthetic organic chemistry have greatly expanded the accessible structural diversity of molecular nanocarbons, accelerating their exploration not only in materials science but also in the biological sciences. In this perspective, we summarize recent progress in the biological applications of molecular nanocarbons. These studies are beginning to establish molecular nanocarbons as a versatile platform at the interface of synthetic chemistry and biology. Continued advances in molecular design, functionalization, and biological evaluation should further expand their roles in imaging, delivery, therapeutics, and biocatalysis, thereby opening new directions for both molecular nanocarbon science and chemical biology. Together, these advances mark the emergence of molecular nanocarbon biology, a new research direction in which precisely synthesized carbon frameworks are designed to interact with living systems in controlled and functional ways.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.